Efectiveness and safety of very low calory diets in obese patients

Purpose: To evaluate effectiveness, safety and adherence of Very Low Calory Diet (VLCD) in patients with obesity. Methods: Observational prospective descriptive study. Patients with BMI >30 kg/m2 who started VLCD were included. We arranged 3 pharmacotherapeutical consultations, picking up the v...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Sáez Belló, C. Segarra Villalba, E. Gras Colomer, P. Frias Ruiz, M. Climente Martí
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/978.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850037760482607104
author M. Sáez Belló
C. Segarra Villalba
E. Gras Colomer
P. Frias Ruiz
M. Climente Martí
author_facet M. Sáez Belló
C. Segarra Villalba
E. Gras Colomer
P. Frias Ruiz
M. Climente Martí
author_sort M. Sáez Belló
collection DOAJ
description Purpose: To evaluate effectiveness, safety and adherence of Very Low Calory Diet (VLCD) in patients with obesity. Methods: Observational prospective descriptive study. Patients with BMI >30 kg/m2 who started VLCD were included. We arranged 3 pharmacotherapeutical consultations, picking up the variables: age, sex, BMI, side effects and number of VLCD cycles. We defined effectiveness as weight loss in absolute and relative terms and weight loss rate (kg/week); safety as incidence and severity of side effects by the Farmacovigilance Spanish System (SEFV); and adherence by a SMAQ adapted questionnaire. Results: 29 women and 15 men were included, with a mean of 42 years. 5 patients did not complete the follow-up. Effectiveness: weight loss average was 7kg (IQR 9,5 a 5,3) and relative of 6,7%, (p < 0.0005). The weight loss rate was 1,2kg per week (IQR 1,6 a 0,9). Safety: 33% of the patients described side effects. All of them were mild (37% constipation, 16% dizziness, 12% anxiety, 5% headache, 2% gases y 2% epigastrical pain). Adherence: 84% of the patients were adherent by the SMAQ adapted questionnaire: 74% in the first cycle and 92% in the following ones. The relation between the number of cycles and the adherence did not get statistical differences (p = 0,1127). Conclusions: Effectiveness and adherence to the treatment could improve in obese patients by setting interdisciplinary measures in the daily clinical practice.
format Article
id doaj-art-6a181fd5b28f4e4f8243ff5525ee12aa
institution DOAJ
issn 1130-6343
2171-8695
language English
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Farmacia Hospitalaria
spelling doaj-art-6a181fd5b28f4e4f8243ff5525ee12aa2025-08-20T02:56:46ZengElsevierFarmacia Hospitalaria1130-63432171-86952014-01-01381505610.7399/FH.2014.38.1.978Efectiveness and safety of very low calory diets in obese patientsM. Sáez Belló0C. Segarra Villalba1E. Gras Colomer2P. Frias Ruiz3M. Climente Martí4Servicio de Farmacia. Hospital Univesitario Dr. Peset. Valencia.Servicio de Farmacia. Hospital Univesitario Dr. Peset. ValenciaServicio de Farmacia. Hospital Univesitario Dr. Peset. Valencia. Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO). Valencia. España.Servicio de Farmacia. Hospital Univesitario Dr. Peset. ValenciaServicio de Farmacia. Hospital Univesitario Dr. Peset. ValenciaPurpose: To evaluate effectiveness, safety and adherence of Very Low Calory Diet (VLCD) in patients with obesity. Methods: Observational prospective descriptive study. Patients with BMI >30 kg/m2 who started VLCD were included. We arranged 3 pharmacotherapeutical consultations, picking up the variables: age, sex, BMI, side effects and number of VLCD cycles. We defined effectiveness as weight loss in absolute and relative terms and weight loss rate (kg/week); safety as incidence and severity of side effects by the Farmacovigilance Spanish System (SEFV); and adherence by a SMAQ adapted questionnaire. Results: 29 women and 15 men were included, with a mean of 42 years. 5 patients did not complete the follow-up. Effectiveness: weight loss average was 7kg (IQR 9,5 a 5,3) and relative of 6,7%, (p < 0.0005). The weight loss rate was 1,2kg per week (IQR 1,6 a 0,9). Safety: 33% of the patients described side effects. All of them were mild (37% constipation, 16% dizziness, 12% anxiety, 5% headache, 2% gases y 2% epigastrical pain). Adherence: 84% of the patients were adherent by the SMAQ adapted questionnaire: 74% in the first cycle and 92% in the following ones. The relation between the number of cycles and the adherence did not get statistical differences (p = 0,1127). Conclusions: Effectiveness and adherence to the treatment could improve in obese patients by setting interdisciplinary measures in the daily clinical practice.http://www.aulamedica.es/fh/pdf/978.pdfObesity;Pharmaceutical attentionVery Low Calory Diet (VLCD).
spellingShingle M. Sáez Belló
C. Segarra Villalba
E. Gras Colomer
P. Frias Ruiz
M. Climente Martí
Efectiveness and safety of very low calory diets in obese patients
Farmacia Hospitalaria
Obesity;
Pharmaceutical attention
Very Low Calory Diet (VLCD).
title Efectiveness and safety of very low calory diets in obese patients
title_full Efectiveness and safety of very low calory diets in obese patients
title_fullStr Efectiveness and safety of very low calory diets in obese patients
title_full_unstemmed Efectiveness and safety of very low calory diets in obese patients
title_short Efectiveness and safety of very low calory diets in obese patients
title_sort efectiveness and safety of very low calory diets in obese patients
topic Obesity;
Pharmaceutical attention
Very Low Calory Diet (VLCD).
url http://www.aulamedica.es/fh/pdf/978.pdf
work_keys_str_mv AT msaezbello efectivenessandsafetyofverylowcalorydietsinobesepatients
AT csegarravillalba efectivenessandsafetyofverylowcalorydietsinobesepatients
AT egrascolomer efectivenessandsafetyofverylowcalorydietsinobesepatients
AT pfriasruiz efectivenessandsafetyofverylowcalorydietsinobesepatients
AT mclimentemarti efectivenessandsafetyofverylowcalorydietsinobesepatients